Scroll Top

ALGAE4IBD

ALGAE4IBD

FROM NATURE TO BEDSIDE- ALGAE BASED BIO COMPOUND FOR PREVENTION AND TREATMENT OF INFLAMMATION, PAIN AND IBD

What if the solution for a chronic disease lies in our ocean, rivers, or lakes? The EU-funded Algae4IBD project will answer this question. Studying compounds from marine and freshwater micro and macroalgae (seaweed) from lab/pilot to market scale, the project will comprehensively research means to transform aquatic natural biological resources into biologically active compounds for the prevention and treatment of inflammatory bowel disease (IBD). Specifically, it will develop algae-based compounds while ensuring algae biodiversity preservation through pioneering cultivation and extraction technologies. Algae4IBD proposes innovative solutions to sustainably use algae-based products with improved nutritional quality to positively impact IBD patients.

OUR ROLE

ENCO is the leader of WP7 LCS and business exploitation and it is responsible for IPR Management.

WEBSITE URL
algae4ibd.eu 

FUNDING PROGRAMME
HORIZON 2020

BUDGET
€ 7.499.520,01

PROJECT DURATION
48 months

START DATE
June 1 st , 2021

PROJECT SOCIAL NETWORK:


Social-twitter-circle


Social-linkedin-circle


Instagram


VIEW ALL PROJECTS

Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.